Bionical Solutions
Bionical Limited is a healthcare services provider based in the United Kingdom, specializing in a range of clinical, commercial, and communication services for pharmaceutical, biotech, and public health companies. The company offers various solutions aimed at improving health outcomes, including MED Select, an interactive tool that helps healthcare providers create tailored educational content for patients, and Quit Manager, a data management system designed for public health stop smoking services. Bionical also provides a National Referral System to support patients with lifestyle-related health conditions. In addition to these services, the company operates as a clinical research organization, offering clinical operations, data management, pharmacovigilance, and regulatory services. Furthermore, Bionical supplies comparator products for clinical trials and supports pharmaceutical clients with early access programs for pre-approved treatments. Established in 2009 and formerly known as Ellis Pharma Limited, Bionical emphasizes innovation and collaboration with leading academics to deliver cutting-edge services that enhance communication and engagement across the healthcare sector.
Top Stages
1 past transactions
Emas Pharma
Acquisition in 2016
Emas Pharma Limited is a contract research organization that specializes in providing a wide range of clinical research and development services to pharmaceutical and biotech companies worldwide. Established in 1996 and based in Hitchin, United Kingdom, with additional offices in the United States and Australia, the company offers comprehensive solutions that include the design and implementation of clinical trials, medical affairs, pharmacovigilance, and regulatory activities. Its clinical operations encompass early-phase trials, late-phase clinical studies, and medical writing services, while drug safety services involve case processing and post-marketing pharmacovigilance. Emas Pharma also supports clients with strategic consultancy in clinical development and product planning, alongside medical affairs services such as pre-launch readiness and marketing material certification. By focusing on the entire product lifecycle, Emas Pharma aims to enhance the development and commercialization of medicines, ensuring compliance with regulatory requirements and providing ongoing support for post-marketing commitments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.